IL87600A0 - Hmg-coa reductase inhibitors,their preparation and pharmaceutical compositions containing them - Google Patents

Hmg-coa reductase inhibitors,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL87600A0
IL87600A0 IL87600A IL8760088A IL87600A0 IL 87600 A0 IL87600 A0 IL 87600A0 IL 87600 A IL87600 A IL 87600A IL 8760088 A IL8760088 A IL 8760088A IL 87600 A0 IL87600 A0 IL 87600A0
Authority
IL
Israel
Prior art keywords
hmg
preparation
pharmaceutical compositions
compositions containing
coa reductase
Prior art date
Application number
IL87600A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL87600A0 publication Critical patent/IL87600A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
IL87600A 1987-09-02 1988-08-30 Hmg-coa reductase inhibitors,their preparation and pharmaceutical compositions containing them IL87600A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9235487A 1987-09-02 1987-09-02

Publications (1)

Publication Number Publication Date
IL87600A0 true IL87600A0 (en) 1989-01-31

Family

ID=22232825

Family Applications (1)

Application Number Title Priority Date Filing Date
IL87600A IL87600A0 (en) 1987-09-02 1988-08-30 Hmg-coa reductase inhibitors,their preparation and pharmaceutical compositions containing them

Country Status (8)

Country Link
EP (1) EP0306264A3 (ja)
JP (1) JPH0196152A (ja)
KR (1) KR890005080A (ja)
AU (1) AU606203B2 (ja)
DK (1) DK485888A (ja)
IL (1) IL87600A0 (ja)
PT (1) PT88364A (ja)
ZA (1) ZA886468B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI893004A (fi) * 1988-06-29 1989-12-30 Merck & Co Inc 5-oxygenerade hmg-coa-reduktas -inhibitorer.
US5073568A (en) * 1988-11-14 1991-12-17 Hoffmann-La Roche Inc. Antipsoriatic agents
US5001148A (en) * 1989-06-07 1991-03-19 E. R. Squibb & Sons, Inc. Mevinic acid derivatives
EP0415488B1 (en) * 1989-08-31 1994-04-20 Merck & Co. Inc. 7-Substituted HMG-COA reductase inhibitors
US5025017A (en) * 1989-09-28 1991-06-18 E. R. Squibb & Sons, Inc. Seco-mevinic acid derivatives useful as antihypercholesterolemic agents and new intermediates
GB9007738D0 (en) * 1990-04-05 1990-06-06 British Bio Technology Compounds
MY106564A (en) * 1990-07-06 1995-06-30 Squibb & Sons Inc Sulfur-substituted mevinic acid derivatives.
US5159104A (en) * 1991-05-01 1992-10-27 Merck & Co., Inc. Process to simvastatin ester
US9107983B2 (en) 2010-10-27 2015-08-18 Warsaw Orthopedic, Inc. Osteoconductive matrices comprising statins
US8877221B2 (en) 2010-10-27 2014-11-04 Warsaw Orthopedic, Inc. Osteoconductive matrices comprising calcium phosphate particles and statins and methods of using the same
WO2012170417A2 (en) 2011-06-06 2012-12-13 Warsaw Orthopedic, Inc. Methods and compositions to enhance bone growth comprising a statin
CN111225672B (zh) 2017-10-16 2023-09-29 清华大学 甲羟戊酸通路抑制剂及其药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294846A (en) * 1979-09-21 1981-10-13 Merck & Co., Inc. Hypocholesteremic fermentation products and products of preparation
EP0204287A3 (en) * 1985-06-04 1987-07-01 Merck & Co. Inc. Process for the preparation of hmg-coa reductase inhibitors with a 3,5-dihydroxypentanoate subunit
US4668699A (en) * 1985-08-05 1987-05-26 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
PT85109A (en) * 1986-06-23 1987-07-01 Merck & Co Inc Process for the preparation of hydroxy-tetrahydropyranone derivatives or corresponding ring opened dihydroxy acids which are hmg-coa reductase inhibitors
FI893004A (fi) * 1988-06-29 1989-12-30 Merck & Co Inc 5-oxygenerade hmg-coa-reduktas -inhibitorer.

Also Published As

Publication number Publication date
KR890005080A (ko) 1989-05-11
ZA886468B (en) 1989-04-26
PT88364A (pt) 1989-07-31
AU2175088A (en) 1989-03-16
EP0306264A3 (en) 1989-08-16
EP0306264A2 (en) 1989-03-08
DK485888A (da) 1989-03-03
DK485888D0 (da) 1988-09-01
JPH0196152A (ja) 1989-04-14
AU606203B2 (en) 1991-01-31

Similar Documents

Publication Publication Date Title
IL79530A0 (en) Hmg-coa reductase inhibiting naphthalenol esters,their preparation and pharmaceutical compositions containing them
IL86464A0 (en) Phosphorus-containing hmg-coa reductase inhibitor compounds and pharmaceutical compositions containing the same
EP0433842A3 (en) 1,2,3-triazole derivatives active as inhibitors of the enzyme hmg-coa reductase and pharmaceutical compositions containing them
AU628696B2 (en) Heterocyclic substituted acylaminothiazoles, their preparation and pharmaceutical compositions containing them
IL111627A0 (en) Substituted phenylpyrimidine compounds, their preparation and pharmaceutical compositions containing them
HUT70544A (en) Heteroaryl-amines as acetyl-cholinesterase inhibitors, pharmaceutical compositions comprising them and process for their preparation
IL79401A (en) Distamycin derivatives,their preparation and pharmaceutical compositions containing them
IL86033A0 (en) Substituted pyrroles,their preparation and pharmaceutical compositions containing them
IL86463A0 (en) Phosphorus-containing hmg-coa reductase inhibitor compounds and pharmaceutical compositions containing the same
IL87644A0 (en) Oxadiazolyl-azabicycloheptanes,their preparation and pharmaceutical compositions containing them
IL87600A0 (en) Hmg-coa reductase inhibitors,their preparation and pharmaceutical compositions containing them
IL87435A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IL88502A0 (en) Pharmaceutical compositions containing an angiotensin converting enzyme inhibitor and methods for the preparation thereof
IL86478A (en) Substituted vinylcephalosporins, their preparation and pharmaceutical compositions containing them
IL88003A (en) Quinoline derivatives,their preparation and pharmaceutical compositions containing them
IL106290A0 (en) Enzyme inhibitors,their preparation and pharmaceutical compositions containing them
IL88617A0 (en) Quinoline derivatives,the preparation thereof and pharmaceutical compositions containing them
IL86926A0 (en) 1h-pyrazole-1-alkanamides,their preparation and pharmaceutical compositions containing them
AU4573793A (en) N-cycloalkylpiperazine derivatives, methods of obtaining them and pharmaceutical compositions containing them
IL89286A0 (en) Quinolone compounds and pharmaceutical compositions containing them
NZ223725A (en) Benzodioxole derivatives and pharmaceutical compositions
IL91605A0 (en) Quinoline derivatives,their preparation and pharmaceutical compositions containing them
IL88673A0 (en) N-hydroxy-5-phenyl-2-furancarboxi-midamides,and pharmaceutical compositions containing them
IL93662A0 (en) Beta-lactam containing compounds,their preparation and pharmaceutical compositions containing them
IL89664A0 (en) Disubstituted pyrroles,their preparation and pharmaceutical compositions containing them